28141584 27206578 27076148 27366674 31387750 27920211 36733717 35836340 24999936 33289681 33353871 - Search Results

Year	Number of Results
2014	1
2016	3
2017	2
2019	1
2020	2
2021	2
2022	1
2023	1

1

Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis.

Zhao H, Bao FF, Liu A. Zhao H, et al. J Infect Dev Ctries. 2017 Jan 30;11(1):1-9. doi: 10.3855/jidc.7999. J Infect Dev Ctries. 2017. PMID: 28141584 Free article. Review.

2

The Borrelia burgdorferi CheY3 response regulator is essential for chemotaxis and completion of its natural infection cycle.

Novak EA, Sekar P, Xu H, Moon KH, Manne A, Wooten RM, Motaleb MA. Novak EA, et al. Cell Microbiol. 2016 Dec;18(12):1782-1799. doi: 10.1111/cmi.12617. Epub 2016 Jul 11. Cell Microbiol. 2016. PMID: 27206578 Free PMC article.

3

Anti-Lyme Subunit Vaccines: Design and Development of Peptide-Based Vaccine Candidates.

Small CM, Mwangi W, Esteve-Gassent MD. Small CM, et al. Methods Mol Biol. 2016;1403:471-86. doi: 10.1007/978-1-4939-3387-7_26. Methods Mol Biol. 2016. PMID: 27076148

4

Seroprevalence of Borrelia burgdorferi antibodies in white-tailed deer from Texas.

Adetunji SA, Krecek RC, Castellanos G, Morrill JC, Blue-McLendon A, Cook WE, Esteve-Gassent MD. Adetunji SA, et al. Int J Parasitol Parasites Wildl. 2016 Jun 13;5(2):168-74. doi: 10.1016/j.ijppaw.2016.06.002. eCollection 2016 Aug. Int J Parasitol Parasites Wildl. 2016. PMID: 27366674 Free PMC article.

5

Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.

Hassan WS, Giaretta PR, Rech R, Ollivault-Shiflett M, Esteve-Gasent MD. Hassan WS, et al. Vaccine. 2019 Sep 3;37(37):5596-5606. doi: 10.1016/j.vaccine.2019.07.092. Epub 2019 Aug 3. Vaccine. 2019. PMID: 31387750

6

Outer Membrane Proteins BB0405 and BB0406 Are Immunogenic, but Only BB0405 Is Required for Borrelia burgdorferi Infection.

Shrestha B, Kenedy MR, Akins DR. Shrestha B, et al. Infect Immun. 2017 Jan 26;85(2):e00803-16. doi: 10.1128/IAI.00803-16. Print 2017 Feb. Infect Immun. 2017. PMID: 27920211 Free PMC article.

7

Generation of multi-layered protein bodies in N. benthamiana for the encapsulation of vaccine antigens.

Schwestka J, Zeh L, Tschofen M, Schubert F, Arcalis E, Esteve-Gasent M, Pedrazzini E, Vitale A, Stoger E. Schwestka J, et al. Front Plant Sci. 2023 Jan 17;14:1109270. doi: 10.3389/fpls.2023.1109270. eCollection 2023. Front Plant Sci. 2023. PMID: 36733717 Free PMC article.

8

Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights.

Chen WH, Strych U, Bottazzi ME, Lin YP. Chen WH, et al. Expert Rev Vaccines. 2022 Oct;21(10):1405-1417. doi: 10.1080/14760584.2022.2102484. Epub 2022 Jul 22. Expert Rev Vaccines. 2022. PMID: 35836340 Free PMC article. Review.

9

Resurrecting the 'yuppie vaccine'.

Willyard C. Willyard C. Nat Med. 2014 Jul;20(7):698-701. doi: 10.1038/nm0714-698. Nat Med. 2014. PMID: 24999936 No abstract available.

10

Human and Veterinary Vaccines for Lyme Disease.

O'Bier NS, Hatke AL, Camire AC, Marconi RT. O'Bier NS, et al. Curr Issues Mol Biol. 2021;42:191-222. doi: 10.21775/cimb.042.191. Epub 2020 Dec 8. Curr Issues Mol Biol. 2021. PMID: 33289681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year